by Pan, Doctor & Spinella
at WashU in St. Louis
- Bench Pilot Work
Formulation demonstrates key requirements
Novel transfusion models - First in vivo POC
Efficacy for hemorrhagic shock and 70% blood exchange
Formulation V1 - First Funding & Support
CDI OAIF Grant ($1M/3Y)
Invention Disclosure (WUSTL)
Bear Cub award ($75K)
BioSTL Fundamentals